Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer.
dc.contributor.author | Chen, Fang | |
dc.contributor.author | Jin, Jian-Yue | |
dc.contributor.author | Hui, Timothy S K | |
dc.contributor.author | Jing, Haiman | |
dc.contributor.author | Zhang, Hong | |
dc.contributor.author | Nong, Yaqing | |
dc.contributor.author | Han, Ying | |
dc.contributor.author | Wang, Weili | |
dc.contributor.author | Ma, Lingyu | |
dc.contributor.author | Yi, Fan | |
dc.contributor.author | Chen, Qingqing | |
dc.contributor.author | Zhang, Yongsheng | |
dc.contributor.author | Fu, Pingfu | |
dc.contributor.author | Yang, Li | |
dc.contributor.author | Xu, Zhiyuan | |
dc.contributor.author | Kong, Feng-Ming Spring | |
dc.date.accessioned | 2022-05-24T12:29:44Z | |
dc.date.available | 2022-05-24T12:29:44Z | |
dc.date.issued | 2022-04-28 | |
dc.identifier.uri | http://hdl.handle.net/10713/18987 | |
dc.description.abstract | A total of 735 patients were eligible. The mean post/preRT PLC ratio was 0.66 (95% CI: 0.64-0.68) and mean EDIC of breast cancer was 1.70Gy (95% CI: 1.64-1.75). Both post/preRT PLC ratio and postRT PLC were significantly correlated with EDIC (P<0.001), with R2 of 0.246. For patients with normal preRT PLC, the post/preRT PLC ratio was better associated with EDIC, and postRT PLC was expressed as PLC preRT × (0.89 - 0.16 × EDIC). For patients with preRT lymphopenia, postRT PLC was better associated with EDIC and it was 1.1 - 0.17 × EDIC. Using binned EDIC as the dose variable, the bootstrap validated NTCPs fit the data nicely with R2 of 0.93, 0.96, and 0.94 for grade-1, grade-2, and grade-3 RIL, respectively. The corresponding EDIC to induce 50% of grade-1, grade-2 and grade-3 RIL was 1.2, 2.1 and 3.7 Gy, respectively. | en_US |
dc.description.uri | https://doi.org/10.3389/fonc.2022.768956 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Media S.A. | en_US |
dc.relation | The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation. | en_US |
dc.relation.ispartof | Frontiers in Oncology | en_US |
dc.rights | Copyright © 2022 Chen, Jin, Hui, Jing, Zhang, Nong, Han, Wang, Ma, Yi, Chen, Zhang, Fu, Yang, Xu and Kong. | en_US |
dc.subject | breast cancer | en_US |
dc.subject | effective dose to the circulating immune cells (EDIC) | en_US |
dc.subject | lymphopenia | en_US |
dc.subject | prediction model | en_US |
dc.subject | radiation | en_US |
dc.title | Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer. | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.3389/fonc.2022.768956 | |
dc.identifier.pmid | 35600350 | |
dc.source.journaltitle | Frontiers in oncology | |
dc.source.volume | 12 | |
dc.source.beginpage | 768956 | |
dc.source.endpage | ||
dc.source.country | Switzerland |